Search results

221 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
UNC study will test therapies to eradicate HIV infection—medicine’s holy grail
Researchers from the UNC Institute for Global Health & Infectious Diseases have received $2.7 million from the National Institutes of Health to develop and test new therapeutic agents that may eradicate HIV infection.
Located in Vital Signs / 2009 / Vital Signs - Sept. 11, 2009
UNC study rewrites textbook on key genetic phenomenon
Because females carry two copies of the X chromosome to males’ one X and one Y, they harbor a potentially toxic double dose of the more than 1000 genes that reside on the X chromosome.
Located in Vital Signs / 2009 / Vital Signs - July 2, 2009
Preliminary Data from Groundbreaking Genome Editing Clinical Trial Encouraging
As part of the phase 1 clinical trial for patients with Hunter syndrome, Joseph Muenzer, MD, PhD, performed the UNC Clinical Translational and Research Center's first-ever in vivo genome editing therapy, achieving a milestone in his own career.
Located in News / 2018 / September
Researchers pinpoint two genes that trigger severest form of ovarian cancer
UNC geneticists led by Terry Magnuson, PhD, and Ron Chandler, PhD, create the first mouse model of ovarian clear cell carcinoma; show how a known drug can suppress tumor growth.
Located in News / 2015 / January
In fruit fly and human genetics, timing is everything
UNC scientists show how DNA is accessed and used during the journey to maturation in fruit flies, and what this might mean to our understanding of how cancers arise.
Located in News / 2017 / May
Gene therapy researchers find viral barcode to cross the blood-brain barrier
UNC School of Medicine scientists led by Aravind Asokan, PhD, reveal how certain gene-carrying AAV vectors can penetrate the brain more efficiently to treat brain and spinal cord conditions, while reducing liver payload.
Located in News / 2018 / February
Scientists identify brain cell types underlying schizophrenia
Karolinska Institutet and UNC School of Medicine researchers, including Patrick Sullivan, PhD, have identified four specific types of brain cells associated with schizophrenia. The findings offer a roadmap for the development of new therapies to target the condition.
Located in News / 2018 / May
Komen recognizes Charles Perou with the Brinker Award, its top scientific honor
Susan G. Komen announced UNC Lineberger researcher Charles M. Perou, PhD, as the recipient of this year's Brinker Award for Scientific Distinction in Basic Science for his contributions to the understanding of breast cancer as distinct molecular subtypes that have prognostic value using cutting-edge cancer genomics tools.
Located in News / 2016 / October
UNC’s Purvis earns NIH Director’s New Innovator Award
With a focus on stem cells, Jeremy Purvis, PhD, wants to tap the power of computer modeling to develop regenerative medicine solutions to medical conditions.
Located in News / 2016 / October
UNC Lineberger to partner in $12 million effort to find treatments for genetically-linked cancers
UNC Lineberger Comprehensive Cancer Center researchers and eight other leading cancer research institutions have won a five-year, $12 million grant to try to find treatments for a group of cancers linked to mutations in the NF1 gene.
Located in News / 2015 / September